COVER MEMBER, METHOD AND TREATMENT MODULE FOR TREATING A BIOLOGICAL SAMPLE ON A SUBSTRATE
20230077728 · 2023-03-16
Assignee
Inventors
- Mark Brian Dockrill (Chadstone, AU)
- Anthony FAVALORO (Richmond, AU)
- Kenneth HE-CHO NG (Donvale, AU)
- Martin Limon (Richmond, AU)
- Peter TOOGOOD (Vermont, AU)
- Stephen John BAGNATO (Mt. Waverley, AU)
Cpc classification
Y10T436/25
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B01L3/5027
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502
PERFORMING OPERATIONS; TRANSPORTING
B01L7/52
PERFORMING OPERATIONS; TRANSPORTING
B01L9/527
PERFORMING OPERATIONS; TRANSPORTING
International classification
Abstract
A cover member for a substrate supporting a biological sample comprises first and second opposing ends, first and second opposing surfaces, a void in the second surface which, when juxtaposed with a substrate, forms a chamber, and a fluid inlet toward the first end and in fluid communication with the void. The void is bounded by void walls having one or more contoured regions for enhancing fluid movement within the chamber. A treatment module for a biological sample comprises the cover member, a support surface for a substrate bearing the biological sample and clamp means operable to releasably retain the cover member in juxtaposition with the substrate for an incubation period. A method for incubating the biological sample with one or more reagents uses the cover member.
Claims
1. A treatment module for a biological sample, the module comprising: a cover member having: opposing ends comprising a first end and a second end; opposing surfaces comprising a first surface and a second surface; a void in the second surface which, when juxtaposed with a substrate, forms a chamber; and a fluid inlet toward the first end and in fluid communication with the void; a support surface configured to support the substrate and a biological sample thereon; a pivot arm operable to pivot the cover member between an open condition and a closed condition relative to the substrate, wherein the cover member comprises a cover member body configured to cooperate with a cover member insert such that when the cover member insert is coupled with the cover member body, the cover member is formed from at least two parts comprising the cover member body and the cover member insert, wherein the cover member insert is configured to form the chamber with the substrate.
2. The treatment module according to claim 1, wherein the cover member insert has a void which, when juxtaposed with the substrate, forms the chamber.
3. The treatment module according to claim 1, wherein the cover member body has grooves into which opposing tongue portions of the cover member insert is slidingly received.
4. The treatment module according to claim 1, wherein the cover member body and the cover member insert are couplable by one or more of magnetic, suction and friction couplings.
5. The treatment module according to claim 1, wherein the cover member insert is removable.
6. The treatment module according to claim 1, wherein the cover member insert is disposable.
7. The treatment module according to claim 1, wherein the cover member insert has an inlet extension arranged to couple with the cover member fluid inlet to facilitate dispensing of reagent into the chamber formed by the cover member insert.
8. The treatment module according to claim 1, wherein the cover member has a fluid outlet toward the second end and the cover member insert has an outlet extension arranged to couple with the cover member fluid outlet.
9. The treatment module according to claim 1, further comprising a substrate retention member configured to retain the substrate on the support surface during opening of the chamber or separation of the cover member and the substrate.
10. The treatment module according to claim 1, further including a wash bay for exposing a surface of the cover member to a wash reagent, wherein optionally, the support surface is shaped to receive the substrate having the sample thereon and, in the absence of a substrate, to form the wash bay.
11. The treatment module according to claim 2, wherein the cover member insert void is bounded by void walls having one or more contoured regions and the one or more contoured regions comprise rounded corners connecting side walls of the void with an end wall of the cover member insert to encourage fluid flow within the chamber.
12. The treatment module according to claim 2, wherein the cover member insert void is bounded by void walls having one or more contoured regions and wherein the one or more contoured regions comprise a rounded taper connecting side walls of the void with an end wall of the cover member insert to encourage fluid flow within the chamber.
13. The treatment module according to claim 2, wherein the cover member insert void is bounded by void walls having one or more contoured regions and wherein the one or more contoured regions comprise rounded cornices connecting the walls of the void with a void ceiling in the second surface of the cover member insert.
14. The treatment module according to claim 2, wherein a void ceiling in the cover member insert has a finish configured to enhance reagent propagation from the fluid inlet extension to the fluid outlet extension, and optionally, wherein the finish is at least one of etched, corrugated, dimpled, sloped, bowed, and rippled.
15. The treatment module according to claim 1, wherein the treatment module is configured for use with an automated sample processing instrument comprising a plurality of treatment modules operable independently under control of a controller of the instrument; and wherein operation of one or more of a clamp, a thermal exchanger, a robot, a negative pressure source and fluid dispenser is under the control of the instrument controller.
16. The treatment module according to claim 15, wherein the robot is configured to position one or both of the substrate and the cover member in the treatment module and optionally, wherein the robot is configured to dispense reagent into the fluid inlet of the cover member during a treatment protocol.
17. The treatment module according to claim 1 wherein the cover member body is removable from the treatment module.
18. The treatment module according to claim 1, wherein the pivot arm is operable to pivot the cover member about a dispersing edge causing fluid to move from the inlet along the substrate from the dispersing edge toward a fluid outlet.
19. The treatment module according to claim 1, wherein the pivot arm is operable to tilt the cover member about a tilt axis extending between the first and second ends.
20. A method including the module of claim 1, including the steps of: a. providing the sample on the substrate; b. positioning the substrate and the cover member coupled with the cover member insert to form the chamber; c. positioning a dispensing probe tip in mating contact with the fluid inlet of the cover member; and d. driving a first volume of a first reagent into the inlet with force sufficient for the first reagent to substantially cover the sample on the substrate; and optionally e. agitating reagent within the chamber.
21. The method according to claim 20, including one or more further steps comprising: a. applying a negative pressure at a fluid outlet of the cover member to draw reagent within the chamber toward the outlet; and b. removing the substrate from a support surface and immersing a second surface of the cover member insert in a wash reagent.
22. A treatment module for a biological sample, the module comprising: a cover member formed from at least two parts including a cover member body and a cover member insert, the cover member having: opposing ends comprising a first end and a second end; opposing surfaces comprising a first surface and a second surface; a void in the cover member insert which, when juxtaposed with a substrate, forms a chamber; and a fluid inlet toward the first end and in fluid communication with the void; a support surface configured to support the substrate and a biological sample thereon; a pivot arm operable to pivot the cover member between an open condition and a closed condition relative to the substrate, wherein the cover member inset is removably couplable with the cover member body.
23. The treatment module according to claim 20, wherein the pivot arm is operable to pivot the cover member about a dispersing edge causing fluid to move from the inlet along the substrate from the dispersing edge toward a fluid outlet.
24. The treatment module according to claim 21, wherein the pivot arm is operable to tilt the cover member about a tilt axis extending between the first and second ends.
25. A method including the module of claim 22, including the steps of: a. providing the sample on the substrate; b. positioning the substrate and the cover member with the cover member insert to form the chamber; c. positioning a dispensing probe tip in mating contact with the fluid inlet of the cover member; and d. driving a first volume of a first reagent into the inlet with force sufficient for the first reagent to substantially cover the sample on the substrate; and optionally e. agitating reagent within the chamber.
26. The method according to claim 25, including one or more further steps comprising: a. applying a negative pressure at a fluid outlet of the cover member to draw reagent within the chamber toward the outlet; and b. removing the substrate from a support surface and immersing a second surface of the cover member insert in a wash reagent.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0102] Embodiments of the invention will now be described in greater detail, by way of example only, with reference to the accompanying drawings. It is to be understood that the embodiments shown are examples only and may not be to scale in all instances. The examples discussed are not to be taken as limiting the scope of the invention as defined in the claims appended hereto. It is to be understood that the parts described are numbered in series (e.g. 1000, 2000, 3000), where like numerals generally designate like parts.
[0103]
[0104]
[0105]
[0106]
[0107]
[0108]
[0109]
[0110]
[0111]
[0112]
[0113]
[0114]
[0115]
[0116]
[0117]
[0118]
[0119]
[0120]
[0121]
[0122]
[0123]
[0124]
[0125]
[0126]
[0127]
DETAILED DESCRIPTION
[0128] It is desirable to perform incubation of small volumes of reagents on a substrate such as a microscope slide. Samples may be treated while slides are retained in a slide tray or individually at sample treatment modules.
[0129] Referring firstly to
[0130]
[0131] In a preferred embodiment, the cover member 1000 is configured for use in an automated sample processing instrument 7000 such as the kind illustrated in
[0132] The instrument uses a robotic arm to dispense a reagent into the cover member inlet. The guide means 1014 guides a dispensing probe 400 of the instrument into the inlet in such a way that the robotic controller need not precisely locate the probe tip 410 inside the inlet well. Rather, the controller need only position the probe tip 410 within the inlet opening 1013 and the guide means 1014 guides reagent dispensed from the probe tip through inlet 1012 and into the chamber 1300.
[0133] In a preferred embodiment, the guide means is configured for contact dispensing of reagent into the inlet. Thus, guide means 1014 comprises a neck 1016 which is shaped to receive a correspondingly shaped dispensing probe tip 410 (
[0134] In one or more embodiments, the neck has compliance so that the mating interface provides a snug fit between the probe tip and the inlet neck to substantially preclude leakage of reagent forced into the inlet using positive pressure. However, use of a gasket or sealing ring at the mating interface is also contemplated. Compliance may be provided by a material property of the cover member including the neck, e.g. when the cover member is manufactured from a compliant material. Alternatively, there may be a compliant material coating in the neck area of the cover member or on the probe tip.
[0135] During dispensing of high value reagent, it is desirable that the dispensing probe tip 410 is brought into mating contact with the neck 1016 as described above. However, such contact may not be necessary for delivery of less expensive bulk fluid reagents such as DI water, alcohol, de-wax solution and the like. This is particularly the case when overdispensing (i.e. dispensing more than one aliquot of reagent) or cleaning. In an embodiment, cleaning involves non-contact dispensing of a cleaning reagent into the inlet and then withdrawing the reagent e.g. using a vacuum, back through the inlet or through the outlet when one is provided.
[0136] The dispensing probe may be e.g. a Fluid Transfer Probe (FTP) robot 7028 (using either a permanent or temporary pipette tip) or Bulk Fluid Robot (BFR) 7014 of an automated instrument 7000 such as the type illustrated in
[0137] In this arrangement, the instrument may have reduced complexity since a dedicated robot for placement of the cover member is not necessary. Once the cover member is disposed in juxtaposition with a slide having a biological sample placed thereon, it is clamped into position using any suitable means and does not move for the duration of the treatment protocol. In
[0138] Advantageously, once the cover member 1000 is positioned and clamped in place, the cover member need not move relative to the slide 200 for the duration of the protocol. Use of a positive pressure to force reagent into the chamber and/or a vacuum to draw reagent through the chamber is sufficient for completing most protocols. Because the treatment protocol can be completed without moving the relative position of the cover member 1000 and the slide 200, there is minimal exposure of the sample to atmospheric air. Accordingly, the risk of sample dehydration is low and at the conclusion of a given protocol the sample may be coverslipped for transport and/or further processing.
[0139] Reagents may remain within the chamber for a period of incubation, before being withdrawn through outlet 1022. During incubation the temperature of the sample (and the reagent) may be modified e.g. by heating or cooling a thermal exchanger associated with the treatment module. Typically, the thermal exchanger is provided in the form of a heating/cooling pad 5300 (
[0140] Typically, high value reagent is forced into the inlet in “contact mode” (i.e. with the probe tip in mating contact with the inlet) using a positive pressure pump such as a syringe pump. Preferably, operation of the syringe pump is under the control of a controller 7060 associated with the automated instrument 7000. Thus, once the probe tip 410 is matingly received within the neck 1014, the syringe pump is activated to deliver an aliquot of reagent into the chamber. With this approach, actively displacing reagent into the chamber using positive pressure minimises the amount of reagent required, and the time for reagent to enter the chamber and cover the sample on the slide.
[0141] During forced delivery of reagent into the chamber 1300, outlet 1022 is vented to atmospheric pressure. Controlling the rate of forced delivery provides control over the fluid front as it moves over the slide, thereby minimising the risk of bubble formation within the chamber. In some protocols, the reagent may be particularly viscous and propagation of the reagent across the slide surface within the chamber may be assisted by application of a vacuum at the outlet 1022. After the required incubation period, the reagent may be evacuated from the chamber by application of a vacuum at the outlet or by flushing with injection of a further reagent. Arrow F (
[0142] A typical treatment protocol involves dispensing bulk fluid reagents into the chamber to wash or otherwise treat the sample. During a wash step, it is desirable to flush the inlet 1012 to remove any residual high value reagent that may have adhered to the inlet walls e.g. during forced delivery of a high value reagent in contact mode. Accordingly, a probe dispensing bulk fluid reagents into the inlet 1012 need not make mating contact with the guide means/neck 1014. In various steps of a protocol it may be desirable for certain reagents to be dispensed in “non-contact mode” such that the mating surface is flushed.
[0143]
[0144]
[0145]
[0146] In
[0147]
[0148] Inlet 1012 in cover member body 1100 is arranged to couple with inlet extension 1012′ in the cover member insert. Similarly, outlet 1022 in the cover member body is configured to couple with the outlet extension 1022′ in
[0149]
[0150] Although the illustrated embodiment show the actuating arm 5110 positioned on the longer side of the cover member 1000, it is to be understood that the actuating arm may also be located at an end of the cover member. Thus the arm 5110 may be operable to open and close the cover member 1000 longitudinally.
[0151] In addition to performing advanced staining protocols, a cover member 1000 incorporating a removable/replaceable cover member insert 1200 may be useful in applications involving Polymerized Chain Reaction (PCR) protocols. In these, protocols, carryover of debris from one protocol to another can lead to contamination and failure of test samples. Accordingly, it is necessary to thoroughly clean or otherwise preclude carryover from one test to the next. Thus, incorporating a removable and ideally, disposable cover member insert 1200 into the cover member 1000 may eliminate or at least reduce the risk of debris carry over or cross-contamination and so may be desirable for applications such as PCR.
[0152]
[0153] In a preferred embodiment, a treatment module 5000 further includes retention means (see e.g.
[0154] Advantageously, the cover member of
[0155]
[0156] A pivot axis 2500 extends through the cover member, perpendicular to a plane which extends orthogonally between the first and second ends. A fluid dispersing edge 2128 is provided, about which the cover member pivots.
[0157] Like cover member 1000, cover member 2000 provides a void 2124 defined by void boundary 2122 which has contoured walls 2126 toward the second end of the cover member. The contoured walls 2126 improve filling and evacuation performance of the chamber.
[0158] In prior art sample staining systems, a common problem has been collection of debris and residual reagent in the chamber boundary formed along the sealing face. Contoured boundary walls 1126 in the present invention guide reagent toward outlet 2022 reducing debris collection. It is to be understood that although outlet 2022 is shown touching the void wall 2122, such contact is not essential. Rather, the outlet opening to the void may be disposed more medially of the cover member such that its opening into the void is not aligned with the void wall.
[0159] The cover member 2000 in
[0160] Now turning to
[0161] In a preferred embodiment, the pivoting action of the cover member is controlled by a controller 7060 of an automated sample processing instrument. Typically, the controller has access to a database 7126 of pre-programmed pivoting actions which enhance or optimise reagent flow across the slide 200 for a plurality of different reagent types and/or protocols employing the various reagent types. In some such protocols, the controller 7060 may also be programmed to agitate the reagent by slight movement of the cover member 2000. Alternatively/additionally, the controller may operate a vacuum pump coupled to the cover member outlet 2020 to apply a vacuum which draws reagent across the chamber or which evacuates reagent from the chamber while the cover member is in the closed condition. The vacuum pump may also be operated in a manner which causes fluid agitation within the chamber.
[0162]
[0163] Now, referring to
[0164]
[0165] In a preferred embodiment, the instrument controller 7060 controls operation of pivot arms 5200 to pivot the cover member 2000 about dispersing edge 2128, gradually moving the cover member between the open (
[0166] At the conclusion of a treatment protocol, the cover member 2000 is separated from the slide and the slide is removed from the treatment module. Separation may be achieved by pivoting the cover member 2000 to the open condition and/or by displacing the cover member from the slide 200 (or vice versa) such that they are separated in the release condition (
[0167]
[0168]
[0169] To tilt the cover member from the open condition to the closed condition, opening cam 5700 lowers pivot arm 5800 past the “open condition” point (typically forming about 10 degrees between the cover member second surface and the slide) causing cover member to rotate about pivot axis 2550. Simultaneous rotation of the pivot arm about pivot axis 5600 shifts cover member pivot axis 2550 toward the slide, such that the cover member gradually approaches the closed condition.
[0170] Advantageously, in the embodiment illustrated in
[0171] In one embodiment, a moisture barrier is provided (such as the barrier illustrated in
[0172]
[0173] The isometric view in
[0174] Preferably, the inlet is adapted to receive multiple dispenses of a reagent so as to form a reservoir 3018 as shown in
[0175]
[0176] In a preferred embodiment, the space 3500 has a height of approximately 2.5 mm for a chamber volume of approximately 130 μl. The stepped profile subtends angles as shown, where α is approximately 15 degrees, β is approximately 60 degrees and θ is approximately 8 degrees. Additionally, contoured void boundaries 3126 (
[0177] A volume of reagent retained in the space 3500 is in contact with both the dispersing channel 3300 and the slide 200. The shape of the channel 3300 is contoured such that forces of surface tension within the fluid prevent it from leaking out of the channel and on to the slide. In a preferred embodiment the cover member 3000 is disposed with side walls 3400 also forming part of the fluid dispersing feature. The side walls 3400 complete the boundary of space 3500 within which the fluid wall forms.
[0178] The arrangement of the channel across a width of the chamber provides a structure which facilitates dispersing of reagent across the slide 200 by slidingly moving the slide 200 and cover member 3000 into overlapping engagement. In an embodiment, this is achieved by moving the slide 200 in a direction S while the cover member 3000 is held stationary, thereby wicking fluid in the channel 3300 and space 3500 along the slide surface in the direction F. Alternatively, the cover member 3000 may be moved in a direction M while the slide 200 is held stationary. This also has the effect of drawing fluid in the dispersing channel 3300 and space 3500 along the slide surface in the direction F. Thus, in one embodiment the reagent is dispersed across the surface of slide 200 by relative movement of the slide and cover member 3000 from an open condition (
[0179] Preferably, the rate of closing is actively controlled according to the flow properties of the reagent. Reagents having higher viscosity require a slower closing speed so that the shear forces generated during closing do not overcome the capillary/surface tension forces which hold the fluid wall within the space 3500 which feeds the fluid front as it is drawn across the slide 200. Dispensing the reagent in this way minimises the risk of formation of bubbles within the chamber 3124.
[0180] In a preferred embodiment, the sliding action of the cover member 3000 and/or slide 200 is controlled by a controller 7060 of an automated sample processing instrument 7000 of the type previously discussed. Typically, the controller has access to a database 7126 of pre-programmed sliding profiles corresponding to various reagents employed in protocols performed by the instrument. Thus, the controller 7060 is configured to control operation of an actuator which optimises reagent flow across the slide surface. An example of such a controller is shown in
[0181] The controller 7060 is shown schematically in
[0182] The controller 7060 also includes driver modules 7102 to 7112 for controlling the motors, pumps, scanners/readers, thermal exchangers and other devices 7114 to 7124 required for operation of the apparatus 7000. Treatment protocols, including staining protocols (e.g. order of reagents to be dispensed by the BFR 7014 and the FTP robot 7028 to the slides and corresponding incubation times) are stored in a protocol database 7126 accessible by the processor 7090 via the communications infrastructure 7096, enabling the processor 7090 to operate the BFR 7014 and the FTP robot 7028 to dispense re-agents to the substrates at the slide treatment stations at the required rate.
[0183] In another embodiment, fluid is dispensed while the cover member 3000 and slide 200 are in a closed condition. This is method is hereinafter referred to as “closed” dispensing and is suitable for more aqueous fluids. Closed dispensing relies on the capillary action of the fluid, and not a spreading action brought about by movement of the slide or cover member, for the reagent to disperse over the slide.
[0184] In both open and closed dispensing methods, it is necessary for the chamber formed by the cover member 3000 and the slide 200 to vent to atmosphere. In the embodiment illustrated, this vent is provided via outlet 3022 which may also be coupled via a valve or solenoid (not shown) to a vacuum source for evacuating reagent from the chamber. However, it is to be understood that an outlet 3022 in the cover member 3000 need not be provided. Instead, it is possible in the closed condition to maintain a gap between the slide 200 and the cover member second end 3020 such that the chamber is not completely closed. Omitting the outlet 3022 in this way and instead providing a gap between the slide and cover member such that the chamber directly vents to atmosphere simplifies cover member design and manufacture, but at the expense of a vacuum coupling site.
[0185] A reagent dispense step in a sample treatment protocol may be followed by dispensing of a second reagent. This may be preceded by evacuation of the chamber by connecting a vacuum at the outlet 3022. Evacuation is enhanced by contoured void boundaries 3126 (
[0186] In a preferred embodiment, the cover member 3000 is provided with a moisture barrier 3900 to control or limit evaporation of moisture from the sample once the reagent has been dispensed over slide 200 and the cover member has been moved to the open condition. An example of a moisture barrier in the form of a physical shroud 3900 is illustrated in
[0187] It is desirable that the moisture barrier 3900 does not interfere with a sample on the slide. Accordingly, the moisture barrier 3900 in
[0188]
[0189] In various aspects, the cover member of the present invention may be adapted to permit agitation of fluid within the chamber. Agitation may be desirable to encourage movement of fluid molecules in the chamber so that there is effective exchange between the surface of the slide (supporting the sample to be processed) and the fluid molecules. Thus, agitation of the fluid may lead to more effective processing yet with smaller reagent volumes within the chamber. Agitation may also increase the rate of reaction for a particular step in a treatment protocol, thereby reducing turnaround time between steps. Additionally, agitation of fluid within the chamber may reduce the impact of bubbles by moving the bubbles about within the chamber to ensure that every surface of the sample is exposed to the reagent fluid during the incubation period. Agitation may be achieved using various means including positive and/or negative pressure applied to an inlet and/or outlet port, introduction and/or withdrawal of fluid from an inlet and/or outlet port or other such means that facilitate the flow of fluid via the inlet and/or outlet ports to generate a turbulence sufficient to promote agitation of the fluid.
[0190] Furthermore, fluid agitation may reduce staining artefacts resulting from the presence of bubbles, enhance uniformity of reagent throughout chamber, minimize “dead zones”, facilitate in situ cleaning and/or washing of a surface of the cover member. Movement of fluid within the chamber may be enhanced by contoured geometry of the chamber walls (e.g. as described with reference to
[0191] Various features of the present invention give rise to cover members which minimise the amount of reagent required for performing steps of treatment protocols of the kind employed by instrument 7000. Ideally, various aspects of the present invention facilitate an effective reaction chamber formed by the cover member which has a volume as small as 120 to 135 μl. Although, closed volumes as small as 30 μl are also contemplated. In some reactions, it may be necessary to provide a larger reaction chamber having closed volumes of e.g. up to 200 μl.
[0192] In one or more embodiments, liquid level sensing for reagents dispensed into the inlet may be desirable. Liquid level sensing may be performed using probe touch technology and/or by monitoring changes in capacitance or pressure at a dispensing probe tip. Alternatively, optical liquid level sensing systems and ultrasonic systems may be employed. Measurements of reagent volumes taken at the inlet, in the chamber and/or through the outlet, can be compared by a controller 7060 on board an automated instrument 7000 to cross check against the volume of dispenses calculated according to the number of protocols performed. This cross check can then be used for inventory control of reagents stored on board the automated instrument.
[0193] Although the various cover member embodiments illustrated herein demonstrate only one outlet, it is to be understood that a plurality of outlets could be provided. However, where a vacuum is applied to enhance fluid movement (including agitation) within the chamber and/or evacuate reagent from the chamber, separate vacuum sources are required for each of the outlets. Thus, in designing a cover member according to the present invention, the skilled addressee will balance complexity and price with performance. Although each of the one or more outlets may be coupled to a vacuum source, embodiments utilising forced pressure dispensing (
[0194] Use of a vacuum during filling of the chamber may reduce the likelihood of bubbles forming within the chamber. Moreover, use of a vacuum to evacuate fluid from the chamber reduces the likelihood of debris remaining within the chamber between reagent dispenses. Another advantage of using a vacuum to evacuate reagent from the chamber is that less reagent may be used, since evacuating the chamber before application of the second reagent minimises the risk of mixing.
[0195] Ideally, the automated instrument controller 7060 accesses a database 7128 of protocol information which is used to control the one or more vacuum sources to apply the correct magnitude and duration of vacuum, depending on the reagent used (e.g. viscous or aqueous) and/or the sample type or section thickness (e.g. skin sample or cytology sample may range in thickness from 1 μm to 15 μm, and preferably 3 μm to 5 μm).
[0196] It is to be noted the inlet may be formed in the cover member body in any orientation, and may exit the cover member on any surface, although in the embodiments illustrated the inlet opening is provided on the first (i.e. top) surface of the cover member. Additionally, it is to be noted that although each embodiment is illustrated with one inlet, provision of multiple inlets is also contemplated. Similarly, as outlined above, multiple outlets are contemplated. It is also to be understood that those outlets may exit the cover member on any surface, although the embodiments illustrated show the outlet exiting the cover member on the first (i.e. top) surface and the front surface (
[0197] Throughout this specification, the embodiments illustrated are described with reference to the slide being maintained in a substantially horizontal orientation. It is to be understood however, that horizontal orientation is not necessarily required and that the support surface may support the slide at an incline. Further, the invention is described in terms of propagation of fluid longitudinally, from the first end toward the second end of the cover member. It is to be understood, however, that the cover member may be configured for transverse fluid flow across the slide employing a wider fluid front although the risk of bubble formation may be higher in this configuration. It is also to be noted that the slide processing according to embodiments of the invention need not be limited to processing in a horizontal orientation
[0198] Preferably, when the inventive cover member is used by an automated sample processing instrument, each slide being processed contains a unique identifier such as a barcode or RFID tag which identifies one or more of the sample type and a protocol to be performed on the sample. That information is detected by a reader device in the instrument and used to schedule dispense actions of BFR and FTP robots within the instrument, according to the required protocol.
[0199] Where the terms “comprise”, “comprises”, “comprised” or “comprising” are used in this specification (including the claims) they are to be interpreted as specifying the presence of the stated features, integers, steps or components, but not precluding the presence of one or more other features, integers, steps or components or group thereof.
[0200] It is to be understood that various modifications, additions and/or alterations may be made to the parts previously described without departing from the ambit of the present invention as defined in the claims appended hereto.